To: | Annual General Meeting of Aqua Bio Technology ASA on 28 June 2024 |
From: | The Nomination Committee of Aqua Bio Technology ASA |
Date: | 21 June 2024 |
Issue no. 10 to the AGM agenda: Election of Board Members
Existing Board of Directors:
Function | Name | Period |
Chair | Jon Olav Ødegård | 2022 - 2024 |
Director | Roger Hofseth | 2019 - 2024 |
Director | Jan Pettersson | 2015 - 2024 |
Director | Camilla H Andersson | 2022 - 2024 |
Director | Birgit M Liodden | 2022 - 2024 |
The election committee has evaluated the Board composition based on the current and coming growth phase in ABT and suggests re-election of directors Jan Pettersson and Chair Jon Olav Ødegård.
Function | Name | Period |
Chair | Jon Olav Ødegård | 2024 - 2025 |
Director | Jan Pettersson | 2024 - 2025 |
Director | David Huggins | 2024 - 2025 |
Director | Gun Anita Lyseng | 2024 - 2025 |
Director | Lena Varming | 2024 - 2025 |
Election period: 1 year (until the next annual general meeting)
Lena Varming:
Co-founder of Cosmed Beauty AS. Works on daily basis as the CEO of Cosmed Beauty AS.
Gun Anita Lyseng:
Co-founder of Skinteam Norge AS. Works on daily basis as the CEO of Skinteam Norge AS.
David Huggins:
David Huggins holds the role of Head of Corporate Development for Hofseth Group since January 2023, and reports directly to Roger Hofseth, its Founder and CEO. David is involved in a broad range of duties across the business including M&A, corporate restructuring, corporate strategy, and financing. Also since January 2023 David holds the role of Head of E-Commerce for Hofseth Biocare and is responsible for its D2C and Amazon marketplace P&L. As of April 2024 David was appointed as a Board Member of Hofseth North America, a wholly owned sales subsidiary with approximately $300m in revenues.
Prior to joining the Hofseth Group, David spent nine years at BlackRock, the world's largest asset manager. He began as a Graduate public equity analyst and by the end of his tenure had progressed to the role of Nutrition thematic fund manager, responsible for approximately $1.5bn in client assets.
Currently, the nomination committee consists of the following members: - Frank Bjordal (chair) - Lennart F. Clausen - Espen Dahl
On behalf of the Nomination committee in Aqua Bio Technology ASA,
___________________________________
Frank Bjordal Chair
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Aqua Bio Technology ASA published this content on 25 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 June 2024 14:46:22 UTC.